Crossing the blood-brain barrier with nanoparticles

Area of Science:

• Neuroscience
• Biomaterials Science
• Pharmacology

Background:

• The blood-brain barrier (BBB) protects the central nervous system (CNS) but hinders therapeutic drug delivery.
• Effective drug delivery across the BBB is crucial for treating neurological diseases.

Purpose of the Study:

• To review and analyze advancements in nanoparticle (NP)-mediated drug delivery across the BBB over the past decade.
• To provide a comprehensive overview of traditional and novel nanocarriers for BBB penetration.

Main Methods:

• Literature review of NP-mediated drug delivery systems for BBB crossing.
• Categorization of NPs into traditional (e.g., PLGA, liposomes) and novel (e.g., carbon quantum dots) types.
• Analysis of BBB penetration mechanisms for various nanocarrier systems.

Main Results:

• Nanoparticles represent an effective and non-invasive strategy for drug delivery across the BBB.
• Various traditional and novel nanocarriers demonstrate potential for enhanced CNS drug delivery.
• Understanding BBB penetration mechanisms is key to optimizing NP-based therapies.

Conclusions:

• Nanoparticle-mediated drug delivery shows significant promise for overcoming BBB limitations in CNS disease treatment.
• Continued research into diverse nanocarrier systems and their BBB interaction mechanisms is warranted.
• This review provides a consolidated resource on NP strategies for improving drug delivery across the BBB.